Zentalis advances azenosertib toward potential ovarian cancer approval in 2026 Jan 6, 2026 08:12AM
Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2 at Leerink Partners Nov 11, 2025 04:50AM
Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 16c Nov 10, 2025 04:07PM
Zentalis to present four azenosertib studies at cancer conference Oct 13, 2025 04:07PM
Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q2 EPS by 17c Aug 6, 2025 06:10PM


Jun 2, 2025 06:56AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
May 14, 2025 04:22PM Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q1 EPS by 1c
Mar 27, 2025 07:54AM Stifel Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Mar 27, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Mar 26, 2025 04:20PM Zentalis Pharmaceuticals (ZNTL) Files $250M Mixed Shelf
Mar 17, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Jan 30, 2025 06:40AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at H.C. Wainwright
Jan 29, 2025 01:58PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $2.50 at Jefferies
Jan 29, 2025 10:18AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at Oppenheimer
Jan 29, 2025 07:09AM Zentalis Pharmaceuticals (ZNTL) Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Jan 28, 2025 04:07PM Zentalis Pharmaceuticals (ZNTL) Announces Strategic Restructuring to Support Late-Stage Azenosertib Development
Dec 12, 2024 07:04AM Zentalis Pharmaceuticals (ZNTL) Announces Management Appointments
Nov 13, 2024 08:01AM Zentalis Pharmaceuticals (ZNTL) Announces Executive Leadership Changes
Sep 16, 2024 12:18PM TD Cowen Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
Sep 16, 2024 11:55AM Oppenheimer Reiterates Outperform Rating on Zentalis Pharmaceuticals (ZNTL)
Sep 16, 2024 07:01AM Zentalis Pharmaceuticals (ZNTL) Announces FDA Lifted Partial Clinical Hold on Azenosertib Studies
Jun 20, 2024 06:10AM UBS Downgrades Zentalis Pharmaceuticals (ZNTL) to Neutral
Jun 18, 2024 02:19PM Jefferies Downgrades Zentalis Pharmaceuticals (ZNTL) to Hold
Jun 18, 2024 01:32PM Morgan Stanley Downgrades Zentalis Pharmaceuticals (ZNTL) to Equalweight
Jun 18, 2024 12:13PM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $20 at H.C. Wainwright
Jun 18, 2024 11:17AM Zentalis Pharmaceuticals (ZNTL) PT Lowered to $10 at Stifel
Jun 18, 2024 09:31AM Wells Fargo Downgrades Zentalis Pharmaceuticals (ZNTL) to Equal Weight
Jun 18, 2024 07:32AM Zentalis Pharmaceuticals (ZNTL) Resumes Trading, Down 29%
Jun 18, 2024 07:00AM Zentalis Pharmaceuticals (ZNTL) Provides Update on Azenosertib Clinical Development Program